We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Vigilance Guideline Encourages Range of Educational Materials
EMA Vigilance Guideline Encourages Range of Educational Materials
The European Medicines Agency is advising drugmakers to create a separate program to assess the effectiveness of risk-minimization efforts for each marketed drug.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor